Entera Bio (ENTX) Long-Term Investments (2020 - 2026)
Entera Bio (ENTX) posted quarterly Long-Term Investments of $6000.0 for Q1 2026, little changed year-on-year from $6000.0 in Q1 2025, and little changed on a QoQ basis from $6000.0 in Q4 2025.
Entera Bio (ENTX) Long-Term Investments (2020 - 2026) Analysis & Trends
Entera Bio (ENTX) has reported Long-Term Investments for 7 consecutive years, with $6000.0 the latest figure, recorded in Q1 2026.
- Quarterly Long-Term Investments changed 0.0% year-over-year to $6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $6000.0, changed 0.0% from the prior year.
- Long-Term Investments steadied at $6000.0 in Q1 2026 per ENTX's latest filing, from $6000.0 in the prior quarter.
- Over the last five years, Long-Term Investments for ENTX reached as high as $46000.0 in Q1 2022 and fell as low as $6000.0 in Q3 2022.
- A 5-year average of $10705.9 and a median of $6000.0 in 2022 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments sank 86.96% — and 2023, when it changed 0.0%.
- Year by year, Long-Term Investments stood at $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then changed by 0.0% to $6000.0 in 2025, then changed by 0.0% to $6000.0 in 2026.
- According to Business Quant data, Long-Term Investments over the past three periods registered $6000.0, $6000.0, and $6000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 505,194.89 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 46,000.00 |
| Dec 31, 2020 | 47,000.00 |